Esperance Pharmaceuticals is Profiled in this Database

Updated At 31 May, 2012

Partial description of this company

First-in-class oncology therapeutics to treat female and male cancers utilizing membrane-disrupting peptides to target cancer cells without harming healthy tissue

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Esperance Pharmaceuticals plus 4816 other startups.

Start Free 7 Day Trial Now

Learn More About Esperance Pharmaceuticals

Technology/product details

Revenue projections

Capital raised to date

Growth strategy